Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Dobutamine
Dobutamine hydrochloride 14.01mg/mL
equivalent to dobutamine 12.5mg/mL
Concentrate for infusion
REX Medical Limited
Bioindustria Laboratorio Medicinali SpA, Alessandria, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Mucosoothe
Lidocaine hydrochloride monohydrate 21.3mg/mL
equivalent to lidocaine hydrochloride 2%w/v
Oral topical gel
Orion Laboratories (NZ) Limited
Orion Laboratories Pty Limited t/a Perrigo Australia, Perth, Australia
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Relistor
Methylnaltrexone bromide 12mg/0.6mL
Solution for injection
Link Pharmaceuticals Limited
Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
|
Dated this 28th day of April 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz